Skip to main content

Table 4 Effect of bioscaffolds on hydroxyproline and hexosamine contents in animals

From: Design and evaluation of atorvastatin-loaded chitosan-hydroxyapatite composite bioscaffolds for wound-healing activity

Groups Hydroxyproline content (mg/gm) Hexosamine content (mg/gm)
Day 0 Day 11 Day 0 Day 11
Control 1.312 ± 0.035 0.828 ± 0.062 0.584 ± 0.050 0.123 ± 0.056
Hbc3 2.024 ± 0.069 4.581 ± 0.23 * 2.718 ± 0.63 3.664 ± 0.27 *
Hcc3 3.381 ± 0.151 11.257 ± 0.079 *** 0.767 ± 0.32 10.524 ± 0.203 ***
  1. Data are represented as mean ± S.D. (n = 6). Significantly different at *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison to control group. Hbc3 containing 1.5 g of calcium chloride cross-linked with Hac1; Hcc3 containing 750 mg of atorvastatin loaded on Hbc3